news
Biotechnology/pharmaceutical services outsourcing market worth $92.9bn by 2025
The global biotechnology services outsourcing market is expected to reach USD 92.9 billion by 2025, according to a report by Grand View Research, Inc...
List view / Grid view
Johnson & Johnson
article
Joining the dots at Janssen
As part of EPR’s Women in Pharma series, Catherine Owen, President of Infectious Disease and Vaccines at Johnson & Johnson, talks to Science Editor Dr Zara Kassam about keeping up with the competition, innovation and grasping the breadth of business...
news
Experimental treatment for Niemann-Pick disease appears safe
An experimental drug has appeared to slow the progression of Niemann-Pick disease type C1...
news
Relocating the EMA: An open letter from EFPIA and Pharma Heads of Research
16 May 2017 | By European Federation of Pharmaceutical Industries and Associations (EFPIA)
The EMA is a world class regulator, whose scientific recommendations are a vital element of the ongoing effort to provide EU citizens with quality medicines
article
The top 21… wealthiest pharma companies
European Pharmaceutical Review has been keeping the industry informed for 21 years and continues to bring insights into current and emerging technologies, contributions from recognised figures in the life science community and of course, the latest and most up to date news. To celebrate our success, we will be counting down…
news
Amorsa to collaborate with J&J on treatment-resistant depression therapy
5 January 2017 | By Niamh Marriott, Digital Editor
Amorsa has announced a research, option and license agreement with Janssen to develop and commercialise a novel small molecule drug candidate for depression...
news
GSK tops list ranking big pharma’s global access to medicine
14 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Read how the 2016 Access to Medicine Index ranks the top 20 pharmaceutical companies on their efforts to improve access to medicine in low- and middle-income countries...
news
Janssen submits EU application for rheumatoid arthritis drug
16 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Sirukumab is a human monoclonal IgG1 kappa antibody that targets the cytokine IL-6, a protein believed to play a role in autoimmune rheumatoid arthritis...
article
Spectroscopy In-Depth Focus 2016
In this Spectroscopy In-Depth Focus: The benefits of NIRS in monitoring and controlling a crystallisation process; Pharmaceutical applications of terahertz spectroscopy and imaging; and much more...
news
FDA grants breakthrough therapy designation for depression drug
16 August 2016 | By Janssen
Following succesful phase II trials, the FDA have granted a Breakthrough Therapy Designation for esketamine, an investigational antidepressant medication...
news
Pharma calls for collective action to combat antimicrobial resistance
21 January 2016 | By Victoria White
More than 80 companies and organisations have signed the Declaration on Combating Antimicrobial Resistance (AMR), an industry-wide call to action...
news
J&J announces new global commitments to end HIV infection in girls and women
2 December 2015 | By Victoria White
Johnson & Johnson has announced four new public-private partnerships to significantly reduce the burden of HIV incidence, especially among adolescent girls...
news
Johnson & Johnson to acquire Novira Therapeutics
5 November 2015 | By Victoria White
The acquisition includes Novira's portfolio of novel antivirals, including its lead candidate, NVR 3-778...
news
7th Global Healthcare Conference
3 November 2015 | By London Business School
The Future of Healthcare - striking a balance between patients, value and innovation. Monday 7 December 2015...
news
J&J and Norvatis to fight it out in the axSpA treatment space
22 July 2015 | By Victoria White
Stelara has progressed into Phase III development for axSpA and, following its anticipated approval, is forecast to achieve sales of $244.7 million in 2024...
